首页|期刊导航|中国实验方剂学杂志|茵陈蒿汤对胆汁淤积性肝损伤的干预作用及调控机制

茵陈蒿汤对胆汁淤积性肝损伤的干预作用及调控机制OA

Intervention Effect and Regulation Mechanism of Yinchenhao Tang on Cholestatic Liver Injury

中文摘要英文摘要

胆汁淤积性肝损伤是指由各种原因导致的胆汁生成、分泌和排泄障碍诱发胆汁淤积,进而引起肝脏损伤、代谢失调和功能紊乱的肝胆系统疾病,可进一步发展为肝纤维化、肝硬化、肝衰竭甚至导致死亡.目前临床治疗的首选药物为熊去氧胆酸,但存在不良反应和部分患者不耐受的现实问题.茵陈蒿汤是中医治疗黄疸阳黄证的代表方剂,具有"清热利湿退黄"等功效,在长期临床应用中表现出了良好的疗效,且现代药理学研究发现该方具有抗炎、抗氧化、调节胆汁酸平衡、抑制肝细胞凋亡等保肝作用.对近年茵陈蒿汤治疗胆汁淤积性肝损伤的相关临床及动物实验研究进行整理归纳后发现,茵陈蒿汤可通过调节胆汁酸代谢与排泄、减轻炎症反应、抑制氧化应激、缓解内质网应激(ERS)、抑制肝细胞凋亡、保护肠道黏膜屏障等作用机制干预胆汁淤积性肝损伤的疾病进程.通过对目前研究证实的茵陈蒿汤调控胆汁淤积性肝损伤相关分子机制进行系统阐述,以期为茵陈蒿汤的临床应用和深入研究提供参考.

Cholestatic liver injury refers to the bile production,secretion,and excretion disorder caused by various reasons.It induces liver injury,metabolic disorders,and dysfunction of the hepatobiliary system,which can further develop into liver fibrosis,cirrhosis,liver failure,and even death.At present,the preferred drug for clinical treatment is ursodeoxycholic acid,which,however,induces adverse reactions and is intolerant in some patients.Yinchenhao Tang is a representative prescription of traditional Chinese medicine for the treatment of jaundice due to Yang jaundice.It has the effects of clearing heat,eliminating dampness,and removing jaundice and has shown good therapeutic effect in long-term clinical application.Modern pharmacological studies have found that this prescription has anti-inflammatory,anti-oxidation,bile acid balance-regulating,hepatocyte apoptosis-inhibiting and other liver-protecting effects.This paper reviews the relevant clinical and animal experimental studies on Yinchenhao Tang in the treatment of cholestatic liver injury in recent years.Yinchenhao Tang can intervene in the progression of cholestatic liver injury by regulating bile acid metabolism and excretion,reducing inflammatory response,inhibiting oxidative stress,alleviating endoplasmic reticulum stress,inhibiting hepatocyte apoptosis,and protecting intestinal mucosal barrier.This paper systematically expounds the molecular mechanisms by which Yinchenhao Tang regulates cholestatic liver injury that are confirmed by current research,aiming to provide reference for the clinical application and in-depth study of Yinchenhao Tang.

WANG Linlin;ZHU Zhengwang;ZHAO Jinghan;MA Ruixue;WANG Bing;ZHU Pingsheng;MIAO Mingsan

Henan University of Chinese Medicine,Zhengzhou 450046,China||Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,ChinaHenan University of Chinese Medicine,Zhengzhou 450046,China||Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,ChinaHenan University of Chinese Medicine,Zhengzhou 450046,China||Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,ChinaHenan University of Chinese Medicine,Zhengzhou 450046,ChinaShanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200233,ChinaHenan University of Chinese Medicine,Zhengzhou 450046,China||Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,ChinaHenan University of Chinese Medicine,Zhengzhou 450046,China||Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao,Zhengzhou 450046,China

医药卫生

茵陈蒿汤胆汁淤积胆汁酸代谢与排泄炎症反应细胞凋亡

Yinchenhao Tangcholestasisbile acid metabolism and excretioninflammatory responsecell apoptosis

《中国实验方剂学杂志》 2026 (1)

71-80,10

国家自然科学基金面上项目(82074340)河南省"双一流"创建学科中医学科学研究专项(HSRP-DFCTCM-2023-1-19,HSRP-DFCTCM-2023-8-31,HSRP-DFCTCM-2023-8-32)

10.13422/j.cnki.syfjx.20251692

评论